Clinical trial Recruiting at 1 site Observational Ages 18 to 55 Women only

Pregnancies before a lupus diagnosis

Official title: Pregnancy Outcomes Prior to a Systemic Lupus Erythematosus Diagnosis

Run by University of Algiers · NCT07148115 · Data updated 2026-11-12

See if pregnancies that happened before women were diagnosed with lupus showed early lupus signs and how those pregnancies affected mothers and babies.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexWomen only
Enrollment50 (estimated)
SponsorUniversity of Algiers
Academic / other
Locations2 sites (Aïn Taya, Algiers Province and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 31, 2025
Study endsApril 30, 2026
Registry record updatedDecember 31, 2025
Trial IDNCT07148115 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women diagnosed with SLE after at least one pregnancy, who meet ACR 1997 or EULAR 2019 criteria and can provide access to their pregnancy medical records and attend the Ain-Taya clinic, are the intended participants.

Probably not a fit

Women diagnosed with SLE before any conception, those without accessible pregnancy records, or those unable to attend the Ain-Taya site are unlikely to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective, single-center cohort using medical record review and brief participant interviews to collect obstetrical and systemic data from pregnancies that occurred before a later diagnosis of systemic lupus erythematosus (SLE). Investigators will include women classified as having SLE by ACR 1997 or EULAR 2019 criteria and extract details on each pregnancy, maternal and fetal outcomes, and any systemic or obstetrical signs noted during or before pregnancy. The analysis will describe the presence of prediagnostic systemic signs, report pregnancy outcomes (for example miscarriage, preterm birth, fetal loss), and summarize SLE severity after diagnosis. Results aim to identify patterns that might signal undiagnosed SLE during pregnancy and inform future monitoring and counseling.

Why it matters

Potential benefit: If successful, the findings could help clinicians spot early SLE signs during pregnancy and improve monitoring and counseling for affected mothers and future pregnancies.

How similar studies have gone: Previous retrospective cohorts have suggested obstetrical complications and prediagnostic systemic signs can precede SLE diagnosis, but published data are limited and not definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Women of childbearing age with a history of at least one pregnancy
* Pregnancy occurred before the diagnosis of LES.
* LES was diagnosed after at least one pregnancy.
* The subject is classified as having LES according to the 1997 ACR or EULAR 2019 criteria.

Exclusion criteria:

LES was previously diagnosed prior to any conception.

Where it's running

  • Ain-Taya's Public Hospital
    Algiers, Algeria
    Recruiting
  • Department of internal medicine, Ain-Taya's teaching Public hospital
    Aïn Taya, Algiers Province, Algeria
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.